GlassScriptPhysician profile
Nadia M Pile
NPI 1992019822
$3,291.04
in general payments reported to CMS, 2019-2025
17 companies · $2,686 in 2025
The $2,686 reported for 2025 was more than what 95% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $235 · 2022: $112 · 2023: $203 · 2024: $56.57 · 2025: $2,686.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,513 · Travel and Lodging: $912 · Food and Beverage: $519.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,513.35 |
| Travel and Lodging | $911.99 |
| Food and Beverage | $519.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,428.98 | 2025 | |
| Exeltis, USA INC. | $163.67 | 2023 | Slynd |
| Coopersurgical, INC. | $162.95 | 2019-2025 | Sos |
| Boston Scientific Corporation | $105.75 | 2019 | |
| Galderma Laboratories, L.P. | $86.97 | 2022 | |
| Abbvie INC. | $52.26 | 2019-2025 | |
| Exact Sciences Corporation | $39.97 | 2023-2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $38.93 | 2024-2025 | Veozah |
| Millicent US INC | $36.09 | 2024 | Intrarosa, Femring |
| Bayer Healthcare Pharmaceuticals INC. | $34.22 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $33.07 | 2025 | |
| Allergan, INC. | $28.96 | 2019 | |
| Organon LLC | $21.66 | 2025 | Jada System |
| Merck Sharp & Dohme LLC | $18.53 | 2025 | Gardasil 9 |
| Daiichi Sankyo INC. | $14.84 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $12.72 | 2019 | |
| Lupin INC. | $11.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nadia Pile listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.